These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12651659)

  • 1. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal.
    Multz AS
    Anesth Analg; 2003 Apr; 96(4):1054-1055. PubMed ID: 12651659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate.
    O'Mara K; Gal P; Ransommd JL; Wimmermd JE; Carlosmd RQ; Dimaguilamd MA; Davonzomd C; Smithmd M
    Ann Pharmacother; 2009 Oct; 43(10):1707-13. PubMed ID: 19755621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children.
    Tobias JD
    J Opioid Manag; 2008; 4(4):187-91. PubMed ID: 18837201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial.
    Mondardini MC; Sperotto F; Daverio M; Caramelli F; Gregori D; Caligiuri MF; Vitale F; Cecini MT; Piastra M; Mancino A; Pettenazzo A; Conti G; Amigoni A
    Trials; 2019 Dec; 20(1):710. PubMed ID: 31829274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
    Baddigam K; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(2):118-23. PubMed ID: 15855224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Infusion may Cause Agitation During Procedural Sedation.
    Banik S; Rath GP; Huygen FJ
    Pain Pract; 2016 Jun; 16(5):E89. PubMed ID: 27260117
    [No Abstract]   [Full Text] [Related]  

  • 8. Dexmedetomidine infusion for sedation in the intensive care setting in an infant with airway compromise due to congenital mediastinal neuroblastoma.
    Shiota M; Oda Y; Taniguchi M; Hamabata T; Mizumoto H; Hata D
    Paediatr Anaesth; 2012 Jun; 22(6):603-5. PubMed ID: 22594426
    [No Abstract]   [Full Text] [Related]  

  • 9. Dexmedetomidine to facilitate drug withdrawal.
    Maccioli GA
    Anesthesiology; 2003 Feb; 98(2):575-7. PubMed ID: 12552220
    [No Abstract]   [Full Text] [Related]  

  • 10. Additional experience with dexmedetomidine in pediatric patients.
    Tobias JD; Berkenbosch JW; Russo P
    South Med J; 2003 Sep; 96(9):871-5. PubMed ID: 14513982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU.
    Tobias JD
    J Opioid Manag; 2006; 2(4):201-5. PubMed ID: 17319480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.
    Kukoyi A; Coker S; Lewis L; Nierenberg D
    Hum Exp Toxicol; 2013 Jan; 32(1):107-10. PubMed ID: 23111887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients.
    Shehabi Y; Nakae H; Hammond N; Bass F; Nicholson L; Chen J
    Anaesth Intensive Care; 2010 Jan; 38(1):82-90. PubMed ID: 20191782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury.
    Tang JF; Chen PL; Tang EJ; May TA; Stiver SI
    Neurocrit Care; 2011 Aug; 15(1):175-81. PubMed ID: 20198514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.
    Arpino PA; Kalafatas K; Thompson BT
    J Clin Pharm Ther; 2008 Feb; 33(1):25-30. PubMed ID: 18211613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Infusion of Dexmedetomidine in Critically-ill Children.
    Andreolio C; Piva JP; Baldasso E; Ferlini R; Piccoli R
    Indian Pediatr; 2016 Nov; 53(11):987-989. PubMed ID: 27889726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
    Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
    Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the use of dexmedetomidine in neurocritical care patients.
    Grof TM; Bledsoe KA
    Neurocrit Care; 2010 Jun; 12(3):356-61. PubMed ID: 20217277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE EFFICACY AND SAFETY OF DEXMEDETOMIDINE FOR SEDATION OF PATIENTS DURING PROLONGED MECHANICAL VENTILATION IN INTENSIVE CARE UNITS (RUSSIAN MULTICENTER STUDY RESULTS)].
    Nikoda VV; Gritsan AI; Eremenko AA; Zabolotskikh IB; Kirov MY; Lebedinsky KM; Levit AL
    Anesteziol Reanimatol; 2015; 60(5):47-53. PubMed ID: 26852580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged infusions of dexmedetomidine in critically ill patients.
    Guinter JR; Kristeller JL
    Am J Health Syst Pharm; 2010 Aug; 67(15):1246-53. PubMed ID: 20651314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.